China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Symbol: 000999.SZ

SHZ

60.44

CNY

Markedspris i dag

  • 19.3562

    P/E-forhold

  • 0.6713

    PEG Ratio

  • 59.16B

    MRK Cap

  • 0.02%

    DIV Udbytte

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999-SZ) Årsregnskaber

På diagrammet kan du se standardtallene i dynamik for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ). Virksomhedens omsætning viser gennemsnittet af 7144.644 M, som er 0.131 % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er 4165.555 M, som er 0.128 %. Den gennemsnitlige bruttofortjeneste er 0.556 %. Væksten i nettoindkomst for virksomheden sidste år er 0.165 %, hvilket svarer til 0.118 % % i gennemsnit for hele virksomhedens historie.,

Balance

Når vi dykker ned i den skattemæssige udvikling for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til 0. Et kig tilbage på det seneste år afslører en samlet aktivændring på 0.480. Når det gælder omsætningsaktiver, er 000999.SZ på 22522.003 i rapporteringsvalutaen. En betydelig del af disse aktiver, helt præcist 8226.787, ligger i kontanter og kortfristede investeringer. Dette segment viser en ændring på 1.612%, når det sammenlignes med sidste års data. Virksomhedens langsigtede investeringer, som ikke er dens fokus, ligger på 724.938, hvis nogen, i rapporteringsvalutaen. Dette indikerer en forskel på -75.410% fra den sidste rapporteringsperiode, hvilket afspejler virksomhedens strategiske skift. Virksomhedens gældsprofil viser en samlet langfristet gæld på 1802.932 i rapporteringsvalutaen. Dette tal betyder en ændring fra år til år på 9.079%. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til 18967.142 i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er 0.115%. Et dybere dyk ned i virksomhedens økonomi afslører yderligere detaljer. Nettotilgodehavenderne er vurderet til 8581.24, med en værdiansættelse af varelageret på 5112.5 og goodwill vurderet til 5123.93, hvis der er nogen. De samlede immaterielle aktiver, hvis de findes, værdiansættes til 4078.25.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

balance-sheet.row.cash-and-short-term-investments

31131.858226.83149.74283.9
4022.4
3045.8
2476.4
1708.4
910.8
973.2
1140
1362
1345.9
2022.6
1731.2
1273.2
718.1
824.6
546.7
363.9
643.6
2246.3
1772.3
1313.9
2294.2
1168.5
76.6
252.6

balance-sheet.row.short-term-investments

4438.41873.3-2647.11218.8
200.2
-106.9
-84.8
-77.6
-68.7
-70.2
-61.3
0
-54.3
-31.1
0
0
0
0
0
0
0
0
5
0
0
0
0
0

balance-sheet.row.net-receivables

35661.868581.26071.35659.4
5054.1
5761.2
4512.3
4003.5
2859.3
2461.8
2010.6
2190.9
1944.5
1439.8
1283.2
1345.2
1374.2
5062.1
4743
4777.7
8549.3
6614
2903.8
3821
121.2
414.9
43.7
21.3

balance-sheet.row.inventory

19561.085112.52498.92308.5
1761.6
1432.4
1533.4
1105.2
904.8
910.6
858.3
999.9
823.7
683.5
490.4
418.4
484.3
601.7
407.3
429.7
322.8
372.3
446.1
470.9
520.4
302.8
278.5
283.2

balance-sheet.row.other-current-assets

2087.77601.5268.6226.6
87.1
53.3
54.4
26.6
407.6
867.8
1114.4
622.7
23.7
0.4
0.2
0.4
10
10.1
5.7
5.3
-3940.4
-2807.3
0.1
0.1
1867.9
1256.2
1042.9
669.9

balance-sheet.row.total-current-assets

88442.552252211988.512478.4
10925.2
10292.8
8576.5
6843.6
5082.5
5213.3
5123.3
5175.5
4137.9
4146.3
3505
3037.2
2586.5
6498.5
5702.6
5576.6
5575.3
6425.4
5122.3
5605.9
4803.7
3142.3
1441.6
1227

balance-sheet.row.property-plant-equipment-net

26485.46802.648234237.8
3770.7
3611.7
3526.1
3555.8
3272.3
3076.7
2809
2771.4
2436.6
1977.7
1340.2
1352.3
1256.6
1082.1
996
1009.6
1070.9
1028.4
913.4
776.2
799.3
308.2
216.3
206.2

balance-sheet.row.goodwill

20610.445123.93994.94060.4
4104.6
3353.7
3543.9
3549.8
3142.2
1730.7
707.3
581.9
307
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

16356.234078.32749.92646.6
2586.9
2097.4
2038.9
1965.1
1837.1
1763.5
1611.1
1554.1
1461.4
1319
1161.8
1148.8
1104.6
66.1
55
47.8
52
81.3
83.3
74.4
98.7
35.1
24.8
16.2

balance-sheet.row.goodwill-and-intangible-assets

36966.689202.26744.76707
6691.5
5451.1
5582.8
5514.9
4979.3
3494.2
2318.4
2136
1768.4
1319
1161.8
1148.8
1104.6
66.1
55
47.8
52
81.3
83.3
74.4
98.7
35.1
24.8
16.2

balance-sheet.row.long-term-investments

2002.87724.92948.1-980.1
-23.8
148.8
132.3
91.1
82.6
92.9
256
0
74.1
50
0
0
0
0
0
0
0
0
660.2
0
0
0
0
0

balance-sheet.row.tax-assets

2492.53626.8324.5241.4
150.3
125.8
109.9
112.1
87
91.1
99.3
75.6
61.9
59.6
47.5
51.8
70.8
70.6
0
0
0
0
72.9
0
0
0
0
0

balance-sheet.row.other-non-current-assets

2569.73270293.91623.5
496.2
473.4
102.3
77.9
48.1
51
61.2
84
133.6
46.4
36.6
41.4
33
56
301
409.3
479.4
761.1
-1.9
142.5
188.1
93.9
24.1
18.5

balance-sheet.row.total-non-current-assets

70517.217626.515134.311829.6
11084.9
9810.7
9453.4
9351.8
8469.3
6805.9
5543.9
5067
4474.5
3452.7
2586.1
2594.2
2465
1274.9
1352
1466.7
1602.3
1870.9
1728
993.1
1086.1
437.3
265.2
240.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

158959.7540148.527122.824308
22010.1
20103.5
18029.9
16195.5
13551.7
12019.3
10667.2
10242.5
8612.4
7599
6091.2
5631.4
5051.5
7773.4
7054.6
7043.3
7177.6
8296.2
6850.2
6599.1
5889.9
3579.6
1706.8
1467.9

balance-sheet.row.account-payables

10661.52365.21795.11415.8
1117.6
1027.3
1041.5
1132.1
903.6
924.5
725.7
1033.7
721.3
804.5
606
629.7
713.6
490.9
468.2
540.2
831.5
684.4
790.2
331.1
460.1
403
413
326.4

balance-sheet.row.short-term-debt

6351.272019.9235.1110.7
30.8
30
35.2
530.1
20.1
0.7
36.9
37
79.1
61.3
43
12
95.5
3103.6
3233
3244.8
3388.9
4032.8
2732.7
2739.3
1824.8
245.7
321.5
361

balance-sheet.row.tax-payables

1709.78254.5518.1373.9
387.7
311.4
293.4
277.1
248.7
211.7
207.9
248.5
222.1
112.7
115.2
131.4
158.4
97
110.1
116.1
124.1
111.5
50
67
26.3
87.3
90.7
79.9

balance-sheet.row.long-term-debt-total

7337.291802.915696.7
101.4
10.2
10.2
0.2
499.9
499.7
508.5
501.1
26.3
4.3
2.9
39.5
14.6
15.6
24.7
35.2
60
76.1
21.2
192.3
162.9
17
10
4.9

Deferred Revenue Non Current

2242.3455.5423.2395.1
346.4
355.3
375.4
395.3
384.7
393.6
361
9.8
10.5
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

1527.48---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

14138.216911.75630.2234.5
152.1
22.3
4946.4
448.4
264.9
336.9
228.5
288.6
359.9
200.5
417.5
448.8
328.8
672.7
61.6
128.5
126.4
23.6
31.5
25.6
11.7
20.3
16.1
10.5

balance-sheet.row.total-non-current-liabilities

11689.152474.3916.7819.8
655.6
528.5
544.9
566.3
1043.4
1043.7
1000.6
865.6
346.7
112.8
54.7
69.9
14.6
15.6
45.4
63
68.1
85.5
28.1
193.7
171.3
36.7
16.1
7.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

494.4119.5105.888.7
148.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

61904.8415421.29589.48595.3
7951.1
7221.6
6861.4
6070.8
4830.4
4345.1
3671.7
3881.5
3036.3
2748.5
1627.4
1679.9
1638.8
4889.9
4509.4
4651
4889.8
5202.4
3948.3
3646.9
2909.6
926
959.7
897.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

3952.9988.2988.3978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
753
753
753
753
694.8
519.2

balance-sheet.row.retained-earnings

62863.0516047.313761.412131.5
10581.5
9871.8
8141.1
7154.4
6009.3
4958.3
4176.2
3599.5
2776.4
2063.3
1626
1149.3
694.9
251
-202.7
-365
-484.8
322.8
146.3
76.7
56.7
108.1
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

6444.97754.6673.1549.3
543.8
545.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

2509.2211771586.71622.9
1622.9
1167.9
1707.7
1705.2
1626.8
1634.4
1604.9
1570.4
1554.5
1502.8
1608.1
1558.1
1526.2
1499.9
1620.7
1618.8
1619.8
1607.6
1799.6
1774.2
1772.8
1714.8
0
0

balance-sheet.row.total-stockholders-equity

75770.1418967.117009.615282.5
13727.1
12563.8
10827.7
9838.5
8615
7571.7
6759.9
6148.8
5309.8
4545
4212.9
3686.3
3200
2729.8
2396.8
2232.7
2113.9
2909.3
2698.9
2603.9
2582.5
2575.9
694.8
519.2

balance-sheet.row.total-liabilities-and-stockholders-equity

158959.7540148.527122.824308
22010.1
20103.5
18029.9
16195.5
13551.7
12019.3
10667.2
10242.5
8612.4
7599
6091.2
5631.4
5051.5
7773.4
7054.6
7043.3
7177.6
8296.2
6850.2
6599.1
5889.9
3579.6
1706.8
1467.9

balance-sheet.row.minority-interest

20819.425294.7523.8430.2
331.9
318
340.8
286.2
106.3
102.5
235.6
212.2
266.3
305.6
250.8
265.2
212.6
153.6
148.3
159.6
174
184.5
203.1
348.3
397.7
77.7
52.3
51.5

balance-sheet.row.total-equity

96589.5624261.917533.415712.7
14059
12881.9
11168.5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

158959.75---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

6441.272598.3301238.7
176.3
41.8
47.5
13.5
13.9
22.7
194.6
26.6
19.8
18.9
18.1
17.3
16.2
23.2
275.9
380.9
433.2
697.9
665.2
108.8
112.4
78.6
8.2
7.8

balance-sheet.row.total-debt

13908.273942.3391.1207.4
30.8
30
35.2
530.3
520
500.4
545.4
538
105.4
65.5
45.9
51.5
110.1
3119.2
3257.7
3280
3448.9
4108.9
2753.9
2931.6
1987.7
262.7
331.5
361

balance-sheet.row.net-debt

-12785.17-2411.2-2758.6-2857.7
-3791.4
-3015.8
-2441.1
-1178.1
-390.9
-472.8
-594.6
-824
-1240.6
-1957.1
-1685.3
-1221.7
-608
2294.6
2711
2916.1
2805.3
1862.6
986.6
1617.6
-306.6
-905.7
254.9
108.4

Pengestrømsopgørelse

Det økonomiske landskab for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på 0.637. Virksomheden udvidede for nylig sin aktiekapital ved at udstede 0, hvilket markerer en forskel på -0.016 i forhold til det foregående år. Det er interessant, at en del af virksomhedens aktier, nemlig 0, blev købt tilbage af virksomheden selv. Denne handling resulterede i en ændring på 0.000 fra det foregående år. I mellemtiden er virksomhedens leverandørgæld i øjeblikket på 315.29 i rapporteringsvalutaen. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på -821735320.000 i rapporteringsvalutaen. Dette er en forskydning på -0.669 fra året før. I samme periode har virksomheden registreret 853.71, 957.78 og -1741.8, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på 0.000, med en forskel fra år til år på 0.000. Desuden afsatte virksomheden -988.35 til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet 3180.15, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

3065.732852.924972080.8
1617.5
2139.1
1474.9
1326.5
1207.8
1274.7
1072.1
1214.6
1081.1
815.1
859.1
761.6
541.1
284.1
166.6
116.8
-718.8
223
153.4
124.1
205.8
230.5

cash-flows.row.depreciation-and-amortization

54.35853.7522.7476.2
391.5
334.9
349.4
320.4
282.5
233.7
234.8
231.8
224.7
133.6
117.4
105.5
83.1
69
83.6
72.7
90.4
64.2
63.6
52.7
71.6
56.5

cash-flows.row.deferred-income-tax

-74.4-137.7-63.5-87
-21.1
-8.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

82.91-1724.563.587
21.1
8.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-332.32-17-216.9-946.9
72
47
42.6
-150.4
-137.8
-114.7
-147.7
-32
-164.6
-22.6
-42.2
-42.4
456.2
-21.6
-25.4
-518.1
-1084.8
-433.5
98.3
-145.7
-38.5
-304.9

cash-flows.row.account-receivables

633.69633.7-71.8-674.7
620.9
-820.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-966.01-966-59.7-664.9
-286.8
87
-436
-144.4
-9.6
-61.1
108.1
-130.1
-135.8
-157.3
-102.8
-54.3
135.8
-188.5
55.5
-101
29
57.2
53
-24.8
-48.7
-22.6

cash-flows.row.account-payables

0315.3-21.9458.4
-241.1
774.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-63.5-65.7
-21.1
5.7
478.6
-5.9
-128.1
-53.7
-255.7
98.1
-28.8
134.8
60.6
11.9
320.4
166.9
-80.9
-417.1
-1113.8
-490.8
45.4
-120.9
10.1
-282.3

cash-flows.row.other-non-cash-items

1989.62393203.5260.3
142.9
-549.1
44.4
63.9
39.6
-133.8
25.2
53
70.6
28.7
-86
30.3
35.9
273.8
200.7
351.4
993.5
174.4
180.8
122.3
28
138.6

cash-flows.row.net-cash-provided-by-operating-activities

4707.2000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-780.38-857.2-951.6-870.8
-621.8
-536
-600.4
-374.7
-354.3
-330.6
-341.2
-354.9
-504.5
-409.8
-270
-192.9
-1203.2
-226.8
-135.8
-37.1
-84.6
-135.9
-172.7
-118.8
-170.6
-73.4

cash-flows.row.acquisitions-net

25.5631.1-11.8-120.6
-993.1
73.3
-140.2
-641.2
-1603.6
-1139
-218.8
-479.8
-1136.2
12.2
-7.8
172.9
-65.8
7.3
0.7
13.8
1.3
6.4
26.8
0
5.5
0

cash-flows.row.purchases-of-investments

-4195.27-3182-5675.9-5203.2
-5419.9
-3808.9
-4254.7
-2003
-2530.1
-2514
-2850
-1094.8
0
-5
-12
-79.6
-0.2
-3.6
-7.6
-0.9
-20.1
-150
-22.9
-26.5
-395.7
-467.6

cash-flows.row.sales-maturities-of-investments

2908.422228.64152.14394.8
6285.5
3765.5
4073.4
2420.9
3007.2
3125.6
2380.4
354.2
0
0.1
0.1
0.1
1.4
7.6
42.5
6.7
0.8
13
52.2
0
94.9
0

cash-flows.row.other-investing-activites

-284.8957.889.3
90
-5.4
31.1
46
256.6
68.1
110
26.1
98.9
17.5
221.9
6.5
4.8
-11.2
-25.1
18.8
31.4
-812.8
-262.4
-1081.5
-1116.7
-342.1

cash-flows.row.net-cash-used-for-investing-activites

-2326.47-821.7-2479.2-1790.5
-659.3
-511.4
-890.7
-552.1
-1224.2
-789.8
-919.6
-1549.1
-1541.9
-385
-67.8
-93
-1263
-226.7
-125.2
1.3
-71.2
-1079.2
-379
-1226.8
-1582.6
-883.1

cash-flows.row.debt-repayment

-1446.58-1741.8-462.2-28.5
-1251.8
-535.2
-530.2
-92.3
-0.7
-32.6
-23
-116.3
-139.9
-158.9
-13.1
-57.5
-57.3
-216.1
-1475
-1741.8
-2424
-3137.6
-3492.2
-3446.7
-1025.2
-205.7

cash-flows.row.common-stock-issued

0.28000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

-0.28000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-1076.37-988.3-855.8-491.8
-424.4
-384.8
-491.3
-181.6
-170
-423
-290
-276.6
-256.3
-304.6
-295.5
-201.8
-11.7
-14.6
-117.3
-132
-201
-266.2
-223.4
-211
-99.3
-37.2

cash-flows.row.other-financing-activites

3351.223180.1742.5-132.8
207.6
27.8
588.8
65.4
-53.5
-186.9
-0.9
500.3
74.2
118
51.8
46
90.3
76.5
1470.6
1935.7
2402.5
4551.5
3499.3
4307.2
2326.7
1752.5

cash-flows.row.net-cash-used-provided-by-financing-activities

-97.65450-575.5-653.1
-1468.6
-892.2
-432.6
-208.6
-224.2
-642.5
-313.9
107.3
-321.9
-345.4
-256.8
-213.3
21.3
-154.3
-121.8
62
-222.5
1147.8
-216.3
649.5
1202.2
1509.6

cash-flows.row.effect-of-forex-changes-on-cash

4.9456.3-2.3
-5.1
1
-0.3
-3.8
2
1.4
-0.2
-1.5
-0.1
-1
-2.3
0
-0.7
-0.4
-0.5
-0.1
0
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

2101.653203.7-41.9-575.4
90.9
569.3
587.5
796
-54.3
-171.1
-49.4
24.2
-652.1
223.5
521.4
548.7
-126
224
178
-193.7
-1013.2
96.7
-99.2
-423.8
-113.8
747.1

cash-flows.row.cash-at-end-of-period

25499.516353.52361.42403.2
2978.7
2842.1
2272.8
1685.3
889.3
943.6
1114.7
1343.5
1310.2
1962.3
1687.1
1165.7
616.7
694.9
489.1
674.9
304.4
276.1
179.5
278.7
709.6
1168.5

cash-flows.row.cash-at-beginning-of-period

23397.853149.72403.42978.7
2887.7
2272.8
1685.3
889.3
943.6
1114.7
1164.1
1319.2
1962.3
1738.8
1165.7
617
742.7
470.9
311.1
868.7
1317.6
179.5
278.7
702.5
823.4
421.4

cash-flows.row.operating-cash-flow

4707.24220.43006.41870.5
2224
1971.8
1911.2
1560.4
1392.1
1259.8
1184.4
1467.4
1211.8
954.9
848.3
855.1
1116.4
605.3
425.5
22.8
-719.6
28.1
496.1
153.4
266.9
120.6

cash-flows.row.capital-expenditure

-780.38-857.2-951.6-870.8
-621.8
-536
-600.4
-374.7
-354.3
-330.6
-341.2
-354.9
-504.5
-409.8
-270
-192.9
-1203.2
-226.8
-135.8
-37.1
-84.6
-135.9
-172.7
-118.8
-170.6
-73.4

cash-flows.row.free-cash-flow

3926.823363.22054.8999.7
1602.2
1435.9
1310.9
1185.7
1037.8
929.2
843.2
1112.5
707.3
545.1
578.3
662.1
-86.8
378.5
289.7
-14.3
-804.2
-107.8
323.4
34.6
96.3
47.2

Resultatopgørelse række

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.s omsætning oplevede en ændring på 0.353% sammenlignet med den foregående periode. Bruttofortjenesten for 000999.SZ rapporteres til at være 12604.36. Virksomhedens driftsomkostninger er 9080.31 og viser en ændring på 35.183% fra sidste år. Udgifterne til afskrivninger er 853.71, hvilket er en ændring på 0.213% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være 9080.31, hvilket viser en 35.183% ændring fra år til år. Salgs- og marketingomkostninger er 0, hvilket er en ændring på 0.000% sammenlignet med året før. EBITDA baseret på de seneste tal er 0, hvilket repræsenterer en 0.196% vækst i forhold til året før. Driftsindtægterne er 3524.05, som viser en ændring på 0.196% sammenlignet med året før. Ændringen i nettoindkomsten er 0.165%. Nettoindkomsten for det sidste år var 2852.93.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

income-statement-row.row.total-revenue

25524.282446418079.515320
13637.3
14701.9
13427.7
11119.9
8981.7
7900.2
7276.6
7801.6
6891.1
5525.2
4365.2
4852.7
4316.2
3397.8
2867.9
2969.5
2461.7
2674.5
2165.7
1867.3
1828.1
1476.4
1425.9
1109.8

income-statement-row.row.cost-of-revenue

12125.7411859.78313.16170.8
5119.6
4830.1
4160.4
3907.7
3362.3
3067
2812.2
3089.9
2678.2
2267.4
1686.2
2396.1
2352.9
1780.9
1551.4
1559.2
1363.5
1353.9
1103.3
917
1005.3
635.4
604.7
487.2

income-statement-row.row.gross-profit

13398.5512604.49766.39149.2
8517.6
9871.8
9267.4
7212.2
5619.5
4833.2
4464.4
4711.7
4212.9
3257.8
2678.9
2456.7
1963.3
1617
1316.5
1410.2
1098.2
1320.6
1062.4
950.3
822.8
841
821.2
622.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

700.37---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

380.93---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

7123.52---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-161.15-108.2792.5662.2
625.1
678.3
15.4
7.8
175.5
91.9
39.1
25.7
75.4
28.1
74.2
22.2
16.5
59.7
-13.1
8.5
-9.8
4.5
9.2
47.4
59.3
52.2
46.4
45.9

income-statement-row.row.operating-expenses

9498.499080.367176497.6
6337
7907.7
7550.3
5661.1
4291.2
3555.8
3243.7
3291.2
2950.2
2325.7
1759.1
1553.9
1309.5
1051.6
894.4
1036.5
1380.6
909.9
764.4
797.3
616.1
605.2
649.5
474.9

income-statement-row.row.cost-and-expenses

21624.232094015030.212668.4
11456.7
12737.8
11710.7
9568.8
7653.4
6622.9
6055.8
6381.1
5628.4
4593.1
3445.4
3949.9
3662.4
2832.4
2445.9
2595.8
2744.1
2263.8
1867.7
1714.3
1621.3
1240.7
1254.2
962.1

income-statement-row.row.interest-income

76.05106.973.567
73.7
22.8
31.6
10
12.3
21.9
24.4
29.9
24.2
27.4
18.4
13.1
10.6
18.2
12
44.6
61
65.3
66.5
141.7
78.8
0
0
0

income-statement-row.row.interest-expense

91.8980.821.213.3
5.1
4.4
25.8
28
28.2
27.9
27.6
22.6
8.8
10.5
1.8
9.6
14.4
120.8
198.8
204.7
203.5
189.8
172.3
157.6
102.8
25.1
29.4
21.6

income-statement-row.row.selling-and-marketing-expenses

7123.52---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

192.28225.216.2-28.4
-10.8
39.2
1.8
-32.8
124.9
251.7
38.9
12.5
20.1
15.9
114.2
1.7
-7.8
-181
-249.7
-226.4
-417.1
-149.2
-114.5
13.4
34.5
23.6
17.3
-4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-161.15-108.2792.5662.2
625.1
678.3
15.4
7.8
175.5
91.9
39.1
25.7
75.4
28.1
74.2
22.2
16.5
59.7
-13.1
8.5
-9.8
4.5
9.2
47.4
59.3
52.2
46.4
45.9

income-statement-row.row.total-operating-expenses

192.28225.216.2-28.4
-10.8
39.2
1.8
-32.8
124.9
251.7
38.9
12.5
20.1
15.9
114.2
1.7
-7.8
-181
-249.7
-226.4
-417.1
-149.2
-114.5
13.4
34.5
23.6
17.3
-4

income-statement-row.row.interest-expense

91.8980.821.213.3
5.1
4.4
25.8
28
28.2
27.9
27.6
22.6
8.8
10.5
1.8
9.6
14.4
120.8
198.8
204.7
203.5
189.8
172.3
157.6
102.8
25.1
29.4
21.6

income-statement-row.row.depreciation-and-amortization

510.85853.7704729.5
642.6
630.8
349.4
320.4
282.5
233.7
234.8
231.8
224.7
133.6
117.4
105.5
83.1
69
83.6
72.7
90.4
64.2
63.6
52.7
71.6
56.5
27.8
78.2

income-statement-row.row.ebitda-caps

4353.5---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

3856.8435242947.22457.4
2070.2
2529.4
1703.5
1510.5
1293.7
1442.6
1228
1411.8
1262.1
926.8
962.6
885
635
325.6
258.1
193.3
-649.8
279.8
185.7
126.7
196.2
208.3
143.2
98.5

income-statement-row.row.income-before-tax

4049.123749.22963.42429.1
2059.4
2568.6
1718.9
1518.3
1453.2
1529
1259.6
1433
1282.8
948.1
1034
904.5
646
384.4
208.7
174.5
-679.5
272.9
189.2
170.3
248.4
259.9
189.3
144.1

income-statement-row.row.income-tax-expense

650.56581466.4348.2
441.9
429.5
244
191.8
245.4
254.3
187.5
218.3
201.7
133
174.9
142.9
104.9
100.3
42.1
59.9
39.3
49.8
35.8
46.1
42.7
29.5
30.2
28.6

income-statement-row.row.net-income

3065.732852.92448.82055.1
1597.5
2112.5
1432.1
1301.7
1197.8
1249.2
1035.9
1181.1
1014.1
760.4
816
709.5
500.1
279.8
164.9
119.9
-720.8
208.8
165
121
201.6
220.2
150.8
98.8

Ofte stillede spørgsmål

Hvad er China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) samlede aktiver?

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) samlede aktiver er 40148455933.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er 13268686742.000.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.525.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er 4.011.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er 0.120.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er 0.151.

Hvad er China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er 2852931664.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 3942294961.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 9080313650.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 7026231386.000.